Search by Drug Name or NDC
NDC 29300-0382-01 Carbamazepine 200 mg/1 Details
Carbamazepine 200 mg/1
Carbamazepine is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Unichem Pharmaceuticals (USA), Inc.. The primary component is CARBAMAZEPINE.
Product Information
| NDC | 29300-0382 |
|---|---|
| Product ID | 29300-382_d4ccdef2-d0be-4c67-9123-885b064ea3b8 |
| Associated GPIs | |
| GCN Sequence Number | 004558 |
| GCN Sequence Number Description | carbamazepine TABLET 200 MG ORAL |
| HIC3 | H4B |
| HIC3 Description | ANTICONVULSANTS |
| GCN | 17450 |
| HICL Sequence Number | 001893 |
| HICL Sequence Number Description | CARBAMAZEPINE |
| Brand/Generic | Generic |
| Proprietary Name | Carbamazepine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Carbamazepine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 200 |
| Active Ingredient Units | mg/1 |
| Substance Name | CARBAMAZEPINE |
| Labeler Name | Unichem Pharmaceuticals (USA), Inc. |
| Pharmaceutical Class | Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mo |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA213284 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 29300-0382-01 (29300038201)
| NDC Package Code | 29300-382-01 |
|---|---|
| Billing NDC | 29300038201 |
| Package | 100 TABLET in 1 BOTTLE (29300-382-01) |
| Marketing Start Date | 2022-11-01 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.15003 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | CARBAMAZEPINE 200 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis